Back to Search
Start Over
PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer
- Source :
- Value in Health. 15:A220
- Publication Year :
- 2012
- Publisher :
- Elsevier BV, 2012.
- Subjects :
- Oncology
medicine.medical_specialty
Postmenopausal women
biology
business.industry
Health Policy
Public Health, Environmental and Occupational Health
Cost-effectiveness analysis
medicine.disease
Breast cancer
Hormone receptor
Internal medicine
biology.protein
medicine
Adjuvant therapy
Aromatase
Stage (cooking)
business
Tamoxifen
medicine.drug
Subjects
Details
- ISSN :
- 10983015
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi.dedup.....73dfffcf2c47dbbb9c940a080ce756e4
- Full Text :
- https://doi.org/10.1016/j.jval.2012.03.1186